The treatment of learning, memory, and age-related memory disorders includes administration of a nicotine antagonist. The preferred nicotine antagonists are mecamylamine, a mecamylamine analog, or a mecamylamine stereoisomer. The effective amount of the nicotine antagonist is 0.005-1.00 mg/kg/day. Alternatively, the method utilizes a partial nicotine agonist.
Method of treating cognitive deficits in learning and memory